Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2007 Jan 1;67(1):425; author reply 426.
doi: 10.1158/0008-5472.CAN-06-3037.

The terminology issue for myeloid-derived suppressor cells

Dmitry I Gabrilovich, Vincenzo Bronte, Shu-Hsia Chen, Mario P Colombo, Augusto Ochoa, Suzanne Ostrand-Rosenberg, Hans Schreiber
Comment

The terminology issue for myeloid-derived suppressor cells

Dmitry I Gabrilovich et al. Cancer Res. .
No abstract available

PubMed Disclaimer

Comment in

Comment on

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Yang R, Cai Z, Zhang Y, Yutzy WHt, Roby KF, Roden RB. CD80 in immune suppression by mouse ovarian carcinoma-associated Gr-1+CD11b+ myeloid cells. Cancer Res. 2006;66:6807–15. - PubMed
    1. Huang B, Pan PY, Li Q, et al. Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host. Cancer Res. 2006;66:1123–31. - PubMed
    1. Zea AH, Rodriguez PC, Atkins MB, et al. Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion. Cancer Res. 2005;65:3044–8. - PubMed
    1. Nefedova Y, Nagaraj S, Rosenbauer A, Muro-Cacho C, Sebti SM, Gabrilovich DI. Regulation of dendritic cell differentiation and antitumor immune response in cancer by pharmacologic-selective inhibition of the janus-activated kinase 2/signal transducers and activators of transcription 3 pathway. Cancer Res. 2005;65:9525–35. - PMC - PubMed
    1. Mirza N, Fishman M, Fricke I, et al. All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients. Cancer Res. 2006 September 15; in press. - PMC - PubMed